fda pulling semaglutide Oral Gets Approval for CV Event Reduction in High-risk Diabetes Patients FDA declares semaglutide (Ozempic/Wegovy) shortage

Mechanism of quercetin as a multidrug-resistant reversing compound in oxaliplatin-resistant gastric-cancer cell lines

If a vendor provides only generic COAs without lot numbers, or if the COA appears templated rather than specific to your batch, treat the product with suspicion

These GHK-Cu peptide shots are administered via a quick subcutaneous injection into fatty tissue, such as the abdomen, using a fine insulin syringe

Both medications come with a Boxed Warning about the potential risk of thyroid C-cell tumors

In a study investigating the use of PPIs among nursing home patients in the USA, it was found that 27% of nursing home patients were using PPIs (Rane et al